Global Ganoderma Spore Powder Capsules 麻豆原创 Growth 2024-2030

Publication ID:

LPI08248197

Publication Date:

August 13, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

An oral powdered nutritional supplement containing spores of Ganoderma lucidum with various bioactive components,including polysaccharides,triterpenoids,peptidoglycans,amino acids,fatty acids,vitamins,and minerals.After oral administration of Ganoderma lucidum spore powder capsules,the active components can modulate the immune system,activate dendritic cells,natural killer cells,and macrophages,and regulate the production of certain cytokines,such as tumor necrosis factor-alpha(TNFa),interleukin(IL)1-beta(IL-1b),IL-2,IL-6,and IL-8.This supplement can improve cancer-related fatigue and can be used as a sleep aid while may also have beneficial effects on the heart,lungs,liver,pancreas,kidneys,and central nervous system.
The global Ganoderma Spore Powder Capsules market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淕anoderma Spore Powder Capsules Industry Forecast鈥� looks at past sales and reviews total world Ganoderma Spore Powder Capsules sales in 2023, providing a comprehensive analysis by region and market sector of projected Ganoderma Spore Powder Capsules sales for 2024 through 2030. With Ganoderma Spore Powder Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ganoderma Spore Powder Capsules industry.
This Insight Report provides a comprehensive analysis of the global Ganoderma Spore Powder Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ganoderma Spore Powder Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Ganoderma Spore Powder Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ganoderma Spore Powder Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ganoderma Spore Powder Capsules.
United States market for Ganoderma Spore Powder Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Ganoderma Spore Powder Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Ganoderma Spore Powder Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Ganoderma Spore Powder Capsules players cover China Meheco Great Wall Pharma, Beijing Hua Hern Han Fang, Hezhi Jiakai Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Ganoderma Spore Powder Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Broken Ganoderma Spore Powder Capsules
Non-broken Ganoderma Spore Powder Capsules
Segmentation by Application:
Online Sales
Offline Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
China Meheco Great Wall Pharma
Beijing Hua Hern Han Fang
Hezhi Jiakai Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ganoderma Spore Powder Capsules market?
What factors are driving Ganoderma Spore Powder Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ganoderma Spore Powder Capsules market opportunities vary by end market size?
How does Ganoderma Spore Powder Capsules break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Ganoderma Spore Powder Capsules Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Ganoderma Spore Powder Capsules by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Ganoderma Spore Powder Capsules by Country/Region, 2019, 2023 & 2030
2.2 Ganoderma Spore Powder Capsules Segment by Type
2.2.1 Broken Ganoderma Spore Powder Capsules
2.2.2 Non-broken Ganoderma Spore Powder Capsules
2.3 Ganoderma Spore Powder Capsules Sales by Type
2.3.1 Global Ganoderma Spore Powder Capsules Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Ganoderma Spore Powder Capsules Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Ganoderma Spore Powder Capsules Sale Price by Type (2019-2024)
2.4 Ganoderma Spore Powder Capsules Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Ganoderma Spore Powder Capsules Sales by Application
2.5.1 Global Ganoderma Spore Powder Capsules Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Ganoderma Spore Powder Capsules Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Ganoderma Spore Powder Capsules Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Ganoderma Spore Powder Capsules Breakdown Data by Company
3.1.1 Global Ganoderma Spore Powder Capsules Annual Sales by Company (2019-2024)
3.1.2 Global Ganoderma Spore Powder Capsules Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Ganoderma Spore Powder Capsules Annual Revenue by Company (2019-2024)
3.2.1 Global Ganoderma Spore Powder Capsules Revenue by Company (2019-2024)
3.2.2 Global Ganoderma Spore Powder Capsules Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Ganoderma Spore Powder Capsules Sale Price by Company
3.4 Key Manufacturers Ganoderma Spore Powder Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ganoderma Spore Powder Capsules Product Location Distribution
3.4.2 Players Ganoderma Spore Powder Capsules Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Ganoderma Spore Powder Capsules by Geographic Region
4.1 World Historic Ganoderma Spore Powder Capsules 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Ganoderma Spore Powder Capsules Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Ganoderma Spore Powder Capsules Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Ganoderma Spore Powder Capsules 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Ganoderma Spore Powder Capsules Annual Sales by Country/Region (2019-2024)
4.2.2 Global Ganoderma Spore Powder Capsules Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ganoderma Spore Powder Capsules Sales Growth
4.4 APAC Ganoderma Spore Powder Capsules Sales Growth
4.5 Europe Ganoderma Spore Powder Capsules Sales Growth
4.6 Middle East & Africa Ganoderma Spore Powder Capsules Sales Growth
5 Americas
5.1 Americas Ganoderma Spore Powder Capsules Sales by Country
5.1.1 Americas Ganoderma Spore Powder Capsules Sales by Country (2019-2024)
5.1.2 Americas Ganoderma Spore Powder Capsules Revenue by Country (2019-2024)
5.2 Americas Ganoderma Spore Powder Capsules Sales by Type (2019-2024)
5.3 Americas Ganoderma Spore Powder Capsules Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ganoderma Spore Powder Capsules Sales by Region
6.1.1 APAC Ganoderma Spore Powder Capsules Sales by Region (2019-2024)
6.1.2 APAC Ganoderma Spore Powder Capsules Revenue by Region (2019-2024)
6.2 APAC Ganoderma Spore Powder Capsules Sales by Type (2019-2024)
6.3 APAC Ganoderma Spore Powder Capsules Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ganoderma Spore Powder Capsules by Country
7.1.1 Europe Ganoderma Spore Powder Capsules Sales by Country (2019-2024)
7.1.2 Europe Ganoderma Spore Powder Capsules Revenue by Country (2019-2024)
7.2 Europe Ganoderma Spore Powder Capsules Sales by Type (2019-2024)
7.3 Europe Ganoderma Spore Powder Capsules Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ganoderma Spore Powder Capsules by Country
8.1.1 Middle East & Africa Ganoderma Spore Powder Capsules Sales by Country (2019-2024)
8.1.2 Middle East & Africa Ganoderma Spore Powder Capsules Revenue by Country (2019-2024)
8.2 Middle East & Africa Ganoderma Spore Powder Capsules Sales by Type (2019-2024)
8.3 Middle East & Africa Ganoderma Spore Powder Capsules Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ganoderma Spore Powder Capsules
10.3 Manufacturing Process Analysis of Ganoderma Spore Powder Capsules
10.4 Industry Chain Structure of Ganoderma Spore Powder Capsules
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ganoderma Spore Powder Capsules Distributors
11.3 Ganoderma Spore Powder Capsules Customer
12 World Forecast Review for Ganoderma Spore Powder Capsules by Geographic Region
12.1 Global Ganoderma Spore Powder Capsules 麻豆原创 Size Forecast by Region
12.1.1 Global Ganoderma Spore Powder Capsules Forecast by Region (2025-2030)
12.1.2 Global Ganoderma Spore Powder Capsules Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Ganoderma Spore Powder Capsules Forecast by Type (2025-2030)
12.7 Global Ganoderma Spore Powder Capsules Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 China Meheco Great Wall Pharma
13.1.1 China Meheco Great Wall Pharma Company Information
13.1.2 China Meheco Great Wall Pharma Ganoderma Spore Powder Capsules Product Portfolios and Specifications
13.1.3 China Meheco Great Wall Pharma Ganoderma Spore Powder Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 China Meheco Great Wall Pharma Main Business Overview
13.1.5 China Meheco Great Wall Pharma Latest Developments
13.2 Beijing Hua Hern Han Fang
13.2.1 Beijing Hua Hern Han Fang Company Information
13.2.2 Beijing Hua Hern Han Fang Ganoderma Spore Powder Capsules Product Portfolios and Specifications
13.2.3 Beijing Hua Hern Han Fang Ganoderma Spore Powder Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Beijing Hua Hern Han Fang Main Business Overview
13.2.5 Beijing Hua Hern Han Fang Latest Developments
13.3 Hezhi Jiakai Pharmaceutical
13.3.1 Hezhi Jiakai Pharmaceutical Company Information
13.3.2 Hezhi Jiakai Pharmaceutical Ganoderma Spore Powder Capsules Product Portfolios and Specifications
13.3.3 Hezhi Jiakai Pharmaceutical Ganoderma Spore Powder Capsules Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Hezhi Jiakai Pharmaceutical Main Business Overview
13.3.5 Hezhi Jiakai Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.